Literature DB >> 2155177

Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

M J Francis1, G Z Hastings, B E Clarke, A L Brown, C R Beddell, D J Rowlands, F Brown.   

Abstract

Uncoupled peptides from all seven serotypes of foot-and-mouth disease virus (FMDV) protein VP1 have been used to elicit neutralizing antibody responses in guinea-pigs. The responses were largely serotype specific, although some significant cross-neutralization was observed. Dimeric tandem peptides have also been used to simultaneously elicit neutralizing antibodies to two different FMDV serotypes. The possible existence of structural features common to the B-cell neutralization sites or the guinea-pig helper T-cell sites within all seven peptides are analysed and discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155177      PMCID: PMC1385585     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  T-cell antigenic sites tend to be amphipathic structures.

Authors:  C DeLisi; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

Authors:  R H Meloen; W C Puyk; D J Meijer; H Lankhof; W P Posthumus; W M Schaaper
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

4.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

5.  Serological prospects for peptide vaccines against foot-and-mouth disease virus.

Authors:  N R Parry; E J Ouldridge; P V Barnett; B E Clarke; M J Francis; J D Fox; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

6.  Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination.

Authors:  M J Francis; L Black
Journal:  J Hyg (Lond)       Date:  1983-10

7.  Chemical basis of antigenic variation in foot-and-mouth disease virus.

Authors:  D J Rowlands; B E Clarke; A R Carroll; F Brown; B H Nicholson; J L Bittle; R A Houghten; R A Lerner
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

8.  Immunological priming with synthetic peptides of foot-and-mouth disease virus.

Authors:  M J Francis; C M Fry; D J Rowlands; F Brown; J L Bittle; R A Houghten; R A Lerner
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

9.  Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus.

Authors:  C Kurz; S Forss; H Küpper; K Strohmaier; H Schaller
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

10.  Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.

Authors:  E Pfaff; M Mussgay; H O Böhm; G E Schulz; H Schaller
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  19 in total

1.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.

Authors:  J H Mathews; J T Roehrig; J R Brubaker; A R Hunt; J E Allan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.

Authors:  J H Mathews; J E Allan; J T Roehrig; J R Brubaker; M F Uren; A R Hunt
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.

Authors:  C Burkhart; G Freer; R Castro; L Adorini; K H Wiesmüller; R M Zinkernagel; H Hengartner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  MHC class II restricted recognition of FMDV peptides by bovine T cells.

Authors:  E J Glass; R A Oliver; T Collen; T R Doel; R Dimarchi; R L Spooner
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 6.  Synthetic peptides in biochemical research.

Authors:  D C Hancock; N J O'Reilly; G I Evan
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

7.  Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.

Authors:  R L Yauch; K Kerekes; K Saujani; B S Kim
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.

Authors:  M J Francis; G Z Hastings; F Brown; J McDermed; Y A Lu; J P Tam
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

10.  Cloning and expression of the gene for the Avi-3 antigen of Mycobacterium avium and mapping of its epitopes.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; M Takahashi; Y Fukasawa; M Wada; C Abe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.